In the first part, this academic assignment provides general information about motives for international acquisitions. Moreover, it discusses whether foreign exchange markets and stock markets can be said to be efficient.
The second part critically analyses the Merger of Sanofi-Synthélabo and Aventis by examining the following aspects:
- market position of each company prior to the merger
- motives for the proposed merger
- attack and defence tactics applied by Sanofi-Synthélabo and Aventis
- methods used to finance the merger
- share price movements immediately before during and after the proposed take-over (commenting on the benefits to shareholders of each company)
- company performance in the period following the take-over (reflecting on the initial take-over motives)
Table of Contents
1. Motives for international acquisitions
1.1 Strategic motives
1.2 Market motives
1.3 Economic motives
1.4 Personal motives
1.5 Particularities in international acquisitions
2. Efficiency of foreign exchange and stock markets
2.1 Efficiency of foreign exchange markets
2.2 Efficiency of foreign stock markets
3. Market position of Sanofi-Synthélabo and Aventis prior to the acquisition
3.1 Sanofi-Synthélabo
3.2 Aventis
4. Motives for the acquisition of Aventis by Sanofi
4.1 Increased market share in the United States
4.2 More power in the whole pharmaceutical market
4.3 Fear of generic drugs
4.4 Cancellation of shares
4.5 Undervaluation of Aventis shares
4.6 Cutting costs
5. Attack and defence tactics applied by Sanofi-Synthélabo and Aventis
5.1 First hostile takeover bid of Sanofi-Synthélabo
5.2 Defence tactics of Aventis and agreement to merge
5.3 Second friendly offer
6. Methods used to finance the merger or acquisition (15 marks)
6.1 Cash alternative
6.2 Paper offer
7. Share price movements immediately before during and after the proposed take-over
7.1 Reactions to rumours of a forthcoming merger
7.2 Responses to the first official offer
7.3 Effects on the acceptance of the second friendly bid
7.4 After the definite finish of the merger
8. Company performance in the period following the merger
8.1 Effects on the main shareholders
Objectives and Research Focus
This paper examines the international acquisition of Aventis by Sanofi-Synthélabo, focusing on the strategic, economic, and tactical aspects of the merger. It analyzes the motivations behind the hostile takeover attempt, the subsequent defense strategies employed, and the impact of the transaction on share prices and long-term company performance.
- Motives for international corporate acquisitions and market efficiency.
- Market positions and competitive landscape prior to the merger.
- Strategic rationale for the Sanofi-Aventis integration.
- Analysis of hostile takeover bids and defensive maneuvers.
- Financial methods and share price movements surrounding the deal.
- Post-merger company performance and shareholder value.
Excerpt from the Book
Strategic motives
Acquisitions serve to reach strategic targets like the development of synergy effects. For example Philipp Morris successfully applied its strengths in marketing cigarettes to the acquired Miller Beer company in such an efficient way that Miller could improve its market position from number seven to number two.
An acquisition can also support the strategy to extend a company’s core competences to other branches. By doing this, firms try to gain competitive advantage in other business sectors. For example Honda’s core competence is the construction of internal combustion engines as a power source. They transferred this core competence to various businesses, including cars, motorcycles, outdoor power equipment, generators and lawnmowers.
With every acquisition the market share of a company can be improved significantly. By acquiring new products and brands a company becomes a bigger and more important supplier. It will become able to enhance its reputation and as a result, the market power can be boosted.
Another strategic motive can be to add value to the company by winning new complimentary products, resources or strengths. In 1970, the record label EMI planned to expand on the medical market as they had developed a CT scanner which enabled doctors to see three-dimensional X-rays. They entered the biggest medical market, the USA even if they had no resources, sales network and experience values. As long as they were the only company selling this product they were successful. But soon after that other companies which were used to sell medical equipment pushed them off the market.
Summary of Chapters
1. Motives for international acquisitions: Defines strategic, market, economic, and personal drivers behind corporate acquisitions and their specific benefits.
2. Efficiency of foreign exchange and stock markets: Discusses the market efficiency hypothesis and its implications for speculative forecasts in global markets.
3. Market position of Sanofi-Synthélabo and Aventis prior to the acquisition: Provides an overview of the individual market standing, core products, and financial status of the two companies before the merger.
4. Motives for the acquisition of Aventis by Sanofi: Analyzes the specific reasons for the merger, including market share expansion, cost synergies, and protection against generic competition.
5. Attack and defence tactics applied by Sanofi-Synthélabo and Aventis: Details the hostile takeover process, defense mechanisms like 'White Knight' strategies, and the negotiation path to the final agreement.
6. Methods used to finance the merger or acquisition (15 marks): Explains the financial structure of the deal, utilizing both cash and stock-based financing methods.
7. Share price movements immediately before during and after the proposed take-over: Evaluates market sentiment and share price volatility throughout the various stages of the acquisition process.
8. Company performance in the period following the merger: Reviews the post-merger success, focusing on profitability, growth, and shareholder reactions.
Keywords
Merger, Acquisition, Sanofi-Synthélabo, Aventis, Pharmaceutical Industry, Hostile Takeover, Market Efficiency, Strategic Synergies, Shareholder Value, Generic Drugs, Defence Tactics, Cost Savings, Capital Increase, Stock Performance, Corporate Strategy.
Frequently Asked Questions
What is the primary focus of this assignment?
The assignment focuses on the international acquisition of Aventis by Sanofi-Synthélabo, analyzing the strategic motivations and the financial mechanics of the transaction.
What are the central themes discussed in the work?
The central themes include corporate acquisition strategies, market efficiency, hostile takeover defense tactics, and post-merger financial and stock market performance.
What is the primary research goal?
The goal is to understand why and how the Sanofi-Aventis merger occurred and to evaluate its success through market and performance metrics.
Which scientific methods are applied to analyze the case?
The author uses empirical data on share prices, market statistics, corporate reports, and established management theories to evaluate the acquisition.
What content is covered in the main section of the paper?
The main section covers the history of both companies, the motives for the merger, the hostile bid and defense tactics, financing methods, and the impact of the merger on share values.
What keywords characterize the work?
Key terms include merger, acquisition, pharmaceutical industry, hostile takeover, stock performance, and shareholder value.
How did Sanofi-Synthélabo initially try to acquire Aventis?
Sanofi launched a hostile takeover bid on 25 January 2004, offering a mix of cash and shares that was initially rejected by the Aventis board.
What was the role of the 'White Knight' in this case?
The 'White Knight' refers to Aventis' search for a more favorable merger partner, such as Novartis, to thwart the hostile takeover by Sanofi.
What was the outcome for the major shareholders after the merger?
Major shareholders like L'Oreal and Total saw their voting rights modified, and the merger proved to be a lucrative financial event for them.
How did market participants react to the second friendly offer?
Investors reacted critically, leading to a temporary decline in share prices for both companies as they assessed the risks and potential benefits of the deal.
- Quote paper
- Juliane Kuballa (Author), 2006, Merger of Sanofi-Synthélabo and Aventis, Munich, GRIN Verlag, https://www.grin.com/document/66931
